Clinical Trial Update: Aliskiren in Patients With Idiopathic Membranous Nephropathy [NA]

View source ↗

Summary

A clinical trial evaluating aliskiren for idiopathic membranous nephropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: Mayo Clinic | Conditions: Idiopathic Membranous Nephropathy | NA | Status: WITHDRAWN